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The antibacterial activity of the ethanolic root extract of Cassia occidentalis was examined. A biologically active component was isolated and
identified as emodin by spectroscopic analysis. The bioactive Minimum Inhibitory Concentration (MIC) values of emodin were 7.8103 and
3.9103 mg ml1 against Bacillus subtilis and Staphylococcus aureus, respectively. It was not active against two Gram-negative bacteria
(Klebsiella pneumoniae and Escherichia coli) at the highest concentration (5.0101 mg ml1) tested.
D 2005 SAAB. Published by Elsevier B.V. All rights reserved.Keywords: Cassia occidentalis; Emodin; AntibacterialTable 1
Minimum inhibitory concentrations (mg ml1) of emodin isolated from C.
occidentalis roots against some selected bacteria
Compound tested Bacteriuma
K.p. E.c. B.s. S.a.
Emodin >0.5 >0.5 7.8103 3.9103Cassia occidentalis L. (Leguminaceae) is used in traditional
medicine in the tropical areas of the world. In Peru, the roots
are used as a diuretic and the decoction is made to treat fevers
(Soukup, 1970). The seeds are brewed into a coffee-like
beverage to treat asthma and the flower infusion is used for
bronchitis in the Peruvian Amazon (Rutter, 1990). In Brazil the
roots are considered to be a tonic, febrifuge and diuretic, and
are used against fevers, tuberculosis, anaemia, liver complaints
and as a reconstituent for general weakness and illness
(Coimbra, 1994). In southeastern Nigeria the leaves are used
for fever (Chukwujekwu et al., 2005). Different parts of this
plant have been reported to possess anti-inflammatory (Kuo et
al., 1996), antihepatotoxic (Saraf et al., 1994), antibacterial
(Samy and Ignacimuthu, 2000) and antiplasmodial activities
(Tona et al., 2004). A wide range of the chemical constituents
have been isolated from C. occidentalis, including sennoside
(Christ et al., 1978), anthraquinone glycosides (Lal and Gupta,
1974; Chauhan et al., 2001), fatty oils, flavonoid glycosides
(Purwar et al., 2003), gallactomannan, polysaccharides and
tannins (Kudav and Kulkarni, 1974).
Although C. occidentalis is indigenous to Brazil, it is a
naturalized plant in Nigeria where it is widespread and grows0254-6299/$ - see front matter D 2005 SAAB. Published by Elsevier B.V. All righ
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E-mail address: vanstadenj@ukzn.ac.za (J. van Staden).profusely. It is well incorporated into traditional medicinal
practices in theWest African region, where it is extensively used
against fever. It has been reported to show good antibacterial
activity (Chukwujekwu et al., 2005). The aim of this studywas to
isolate the antibacterial agent(s) from the C. occidentalis roots.
Roots of C. occidentalis L. were collected between May and
June 2002 from southeasternNigeria. The voucher specimenwas
deposited in the Enugu State Herbarium (voucher number-
EFH9009). Plantmaterial was air-dried for twoweeks, powdered
and stored in paper containers for a week prior to extraction.
The air-dried roots (190 g) were extracted with 1 L 80%
aqueous ethanol with sonication for 1 h and then left overnight
on a magnetic stirrer. The extract was filtered through a Bu¨chner
funnel using Whatman No. 1 filter paper. The extraction and
filtration were subsequently repeated three times with 0.5 L 80%ny 72 (2006) 295 – 297
wwts reserved.
Neomycin 1.6103 1.6103 7.8104 6.3103
a Abbreviations: K.p. — K. pneumoniae; E.c. — E. coli; B.s. — B. subtilis;
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pressure at 30 -C. Vacuum liquid chromatography (VLC)
(Merck 9385, 150 g, 630 cm) of the ethanolic extract (15 g),
using a CH2Cl2 :MeOH step gradient (9 :1 to 0 :1), produced
sixteen fractions of which fractions 6 (177 mg) and 7 (190 mg)
eluted with CH2Cl2 :MeOH (4 :1 and 7 :3), respectively, showed
good antibacterial activity in the bioautographic assay. Further
purification by gravity column chromatography (Merck 9385,
127 g, 2.573 cm) using a CH2Cl2 :MeOH step gradient (9 :1 to
0 :1) afforded 68 mg of active fraction. This was finally
separated by preparative TLC (Merck glass plates, 2020 cm,
silica gel 60 F254, 0.25 mm thickness) using CH2Cl2 :MeOH
(15 :1) as the mobile phase. The active compound(s) (14 mg,
appearing as a dark brown band under UV366) was scraped off
the TLC plates, eluted from the silica with absolute ethanol, and
filtered through Millipore filters (0.45 and 0.22 Am) to remove
residual silica. The purity of the isolate was confirmed by TLC
using various solvent systems.
Throughout the isolation procedure antibacterial activity was
determined by the direct bioautographic assay (Hamburger and
Cordell, 1987) using Gram-positive Staphylococcus aureus
(ATCC 12600) as the test organism. The inhibition of bacterial
growth by compounds isolated was indicated as white spots
against a deep red background. The microtitre bioassay (Eloff,
1998) was used to determine the Minimum Inhibitory Concen-
tration (MIC), against S. aureus (ATCC 12600), Escherichia
coli (ATCC 11775), Klebsiella pneumoniae (ATCC 13883) and
Bacillus subtilis (ATCC 6051). Neomycin (100 Ag ml1)
served as a positive control for each bacterium, with solvent
(25% aqueous ethanol) and bacteria free wells being included as
blank controls. The experiment was repeated twice with two
replicates each.
The identity of the isolate was achieved by comparison of
its 1H and 13C NMR spectral data with literature values
(Wang et al., 1996; Fujimoto et al., 1998), and by analysis of
its 2D (HSQC, HMBC, COSY and NOESY) NMR spectra.
These data confirmed the compound as 4,5,7-trihydroxy-2-
methylanthraquinone.
Emodin has previously been found in a wide variety of
botanical and fungal species (Turner and Aldridge, 1983; Wang
et al., 1996; Fujimoto et al., 1998), including other plant
species belonging to the genus Cassia (Kelly et al., 1993). It
has not hitherto been reported from C. occidentalis. It has been
shown to possess both monoamine oxidase (Fujimoto et al.,
1998) and tyrosine kinase (Jayasuriya et al., 1992; Kumar et
al., 1998) inhibitory activity and was reported to act as an
antimicrobial, antineoplastic and cathartic agent (Dictionary of
Natural Products, 2004).
TheMIC results obtained for emodin are presented in Table 1.
Due to the limited amount of the compound obtained, it was
dissolved in 25% aqueous ethanol at a final or stock concentra-
tion of 2 mg ml1. At this concentration, there was no
bacteriostatic effect on the Gram-negative bacteria. This was
not surprising since the crude extract did not exhibit any
bacteriostatic effect on these Gram-negative bacteria in our
previous study (Chukwujekwu et al., 2005). However, emodin
exhibited a remarkable bacteriostatic effect on the Gram-positivebacteria tested, especially S. aureus. It had significantly higher
activity when compared with the results obtained for the crude
extract (Chukwujekwu et al., 2005). Emodin also exhibited a
higher bacteriostatic effect against S. aureus when compared to
the standard neomycin (Fig. 1).
Thus, while our isolate is not a new compound, this is the
first report of its isolation from C. occidentalis.Acknowledgements
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